Heart Rate Variability (hrv) Clinical Trials
2 recruiting trials for Heart Rate Variability (hrv). Eligibility criteria explained in plain English.
TrialFinderData lists 2 Heart Rate Variability (hrv) clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Konya City Hospital (1), Sorlandet Hospital HF (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Universal approach (behavioral, 1 trial), followed by Selective approach, Outdoor therapy.
Track Heart Rate Variability (hrv) trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Heart Rate Variability and Anxiety as Predictors of Emergence Agitation After Septorhinoplasty
This prospective observational study aims to evaluate whether preoperative heart rate variability (HRV) and anxiety are associated with, and can help predict, emergence agitation...
Where Wild Things Grow: Nature- and Activity-based Group Interventions for Neurodivergent Children and Youth
The goal of this action research project is to develop and implement nature- and activity-based group interventions across health care, school and leisure settings in Southern...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Heart Rate Variability (hrv), with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Heart Rate Variability (hrv), review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Heart Rate Variability (hrv), representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.